T 1616/22 (FVIII production/OCTAPHARMA) of 08.07.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T161622.20240708
- Date of decision
- 8 July 2024
- Case number
- T 1616/22
- Petition for review of
- -
- Application number
- 12721821.2
- IPC class
- C12N 5/00C07K 14/755
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- A method of increasing the productivity of eucaryotic cells in the production of recombinant FVIII
- Applicant name
- Octapharma AG
- Opponent name
- WALLINGER RICKER SCHLOTTER TOSTMANN
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56
- Keywords
- Inventive step - effect not made credible within the whole scope of claim
Inventive step - obvious alternative - Catchword
- -
- Citing cases
- T 0091/24
Order
For these reasons it is decided that:
1. The decision is set aside.
2. The patent is revoked.